B. Newstat
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 7
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 1
-
- Lung Cancer Treatments and Mutations 4
- Advanced Breast Cancer Therapies 4
- Co-authors
- Cristina Oliva (5 shared papers)Charles E. Geyer (3 shared papers)Michelle Casey (3 shared papers)David Cameron (4 shared papers)Michelle DeSilvio (3 shared papers)Vicharn Lorvidhaya (2 shared papers)María Koehler (3 shared papers)John Crown (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Breast Cancer Research and Treatment (2 papers)Cancer Research (2 papers)The Oncologist (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
B. Newstat
13 papers receiving 516 citations
Peers
Comparison fields: 5 of 46
- Oncology 395
- Genetics 47
- Pulmonary and Respiratory Medicine 129
- Radiology, Nuclear Medicine and Imaging 91
- Cancer Research 57
Countries citing papers authored by B. Newstat
This map shows the geographic impact of B. Newstat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Newstat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Newstat more than expected).
Fields of papers citing papers by B. Newstat
This network shows the impact of papers produced by B. Newstat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Newstat. The network helps show where B. Newstat may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Newstat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 239 | |
| 2 | 2013 | 120 | |
| 3 | 2008 | 79 | |
| 4 | 2011 | 36 | |
| 5 | 2007 | 26 | |
| 6 | 2010 | 9 | |
| 7 | 2008 | 8 | |
| 8 | 2009 | 5 | |
| 9 | 2009 | 4 | |
| 10 | 2007 | 3 | |
| 11 | 2008 | 2 | |
| 12 | 2011 | 1 | |
| 13 | 2007 | 1 | |
| 14 | 2009 | 1 |
About B. Newstat
B. Newstat is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Molecular Biology and Hematology, having authored 14 papers that have together received 534 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (7 papers), Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Advanced Breast Cancer Therapies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lung Cancer Research Studies (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Oncology (395 citations), Genetics (47 citations), Pulmonary and Respiratory Medicine (129 citations), Radiology, Nuclear Medicine and Imaging (91 citations) and Cancer Research (57 citations). B. Newstat has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Cristina Oliva, Charles E. Geyer, Michelle Casey, David Cameron, Michelle DeSilvio, Vicharn Lorvidhaya, María Koehler, John Crown, Wichit Arpornwirat and Henry Gómez. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, The Oncologist and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.